Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
I’m not sure what they mean there, but I skimmed the article last night and I believe it said there was a reduction in tumor size. So if they mean that happened in all patients, that’s not particularly suspicious. They’re not claiming that the cancer went poof in everyone.
I’m not sure what they mean there, but I skimmed the article last night and I believe it said there was a reduction in tumor size. So if they mean that happened in all patients, that’s not particularly suspicious. They’re not claiming that the cancer went poof in everyone.